<DOC>
	<DOCNO>NCT02276651</DOCNO>
	<brief_summary>Application therapeutic platelet transfusion Regimen patient acute myeloid leukemia complete Remission ( consolidation therapy )</brief_summary>
	<brief_title>Observational Trial Therapeutic Platelet Transfusion Regimen</brief_title>
	<detailed_description>For participant therapeutic regimen platelet transfusion apply : clinically stable patient platelet Transfusion give case bleed WHO IIÂ° high , clinically instable patient platelet transfusion give decretion attend physician . Patients sepsis , septic shock infection Infiltration organ ( e.g . invasive aspergillosis ) , plasmatic coagulation disorder sudden increase headache without neurologic symptom receive prophylactic platelet Transfusion , platelet Count le 10/nl . Otherwise prophylactic platelet Transfusion give irrespective actual platelet Count . As Primary study endpoint The incidence bleed episode WHO grade III IV document . The bleed incidence compare historic cohort .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<criteria>Acute myeloid leukemia complete remission plasmatic coagulopathy history severe bleeding complication chemotherapy induce thrombocytopenia increment platelet platelet transfusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>